The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490).
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D008288:Malaria / Q000188:drug therapy*; D051379:Mice; D010880:Piperidines / Q000494:pharmacology* / Q000627:therapeutic use; D010962:Plasmodium berghei / Q000187:drug effects*; D011319:Primaquine / Q000494:pharmacology; D011739:Pyrimethamine / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology* / Q000627:therapeutic use; D013307:Streptomycin / Q000494:pharmacology; D013426:Sulfaphenazole / Q000494:pharmacology; D013997:Time Factors
D000962:Antimalarials; D004338:Drug Combinations; D010880:Piperidines; D011804:Quinolines; D013426:Sulfaphenazole; D011319:Primaquine; D013307:Streptomycin; D011739:Pyrimethamine